Acumen Hypotension Prediction Index EV1000 Clinical Platform vs Stethee Pro 1
AI Verdict
Choose Acumen Hypotension Prediction Index EV1000 Clinical Platform if…
Choose Acumen Hypotension Prediction Index if your primary goal is to proactively prevent and manage intraoperative or critical care hypotension. This tool is ideal for anesthesiologists and critical care teams who require continuous, real-time hemodynamic monitoring and predictive analytics to anticipate hypotensive events up to 15 minutes in advance, enabling timely interventions based on insights into preload, afterload, and contractility.
View Acumen Hypotension Prediction Index EV1000 Clinical Platform →Choose Stethee Pro 1 if…
Choose Stethee Pro 1 if you need an advanced, AI-enabled digital stethoscope for enhanced cardiac and respiratory diagnostics, particularly in telemedicine or remote monitoring scenarios. This system is best suited for clinicians who require sophisticated sound amplification, real-time AI analysis of heart and lung sounds, and secure data sharing capabilities to augment physical examinations and facilitate remote consultations.
View Stethee Pro 1 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Acumen Hypotension Prediction Index EV1000 Clinical Platform | Stethee Pro 1 |
|---|---|---|
| Pricing | Unknown | $499 usd |
| Deployment | On-premise (integrated with EV1000 clinical platform and HemoSphere advanced monitoring platform) | Cloud, Mobile |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Stethee Pro 1Stethee Pro 1 is a portable, wireless digital stethoscope with a mobile app and cloud portal, offering quick 20-second vital sign capture, making it highly accessible and user-friendly for a broad range of clinicians and telemedicine. Acumen HPI, while valuable, is integrated into a more complex critical care monitoring platform, requiring specific infrastructure and trained personnel.
Clinical Value
Acumen Hypotension Prediction Index EV1000 Clinical PlatformAcumen HPI provides a significant clinical advantage by using machine learning to predict hypotensive events up to 15 minutes in advance and offering insights into the underlying hemodynamic instability, which can proactively prevent adverse patient outcomes in critical settings. Stethee Pro 1 offers enhanced real-time cardiac and respiratory diagnostics, but Acumen HPI's predictive capability for a life-threatening event offers a more immediate and critical clinical impact.
Pricing & Value
Stethee Pro 1Stethee Pro 1 offers transparent pricing with a clear device cost of $499 and a subscription for its web portal, making its value proposition straightforward and accessible for individual practitioners or smaller clinics. Acumen HPI's 'contact-for-pricing' suggests a higher-cost, enterprise-level solution integrated with existing Edwards Lifesciences infrastructure, which lacks immediate pricing transparency.
Enterprise Readiness
Acumen Hypotension Prediction Index EV1000 Clinical PlatformAcumen HPI is developed by Edwards Lifesciences, a major medical device company, and is designed for integration with their HemoSphere Advanced Monitoring Platform, indicating robust enterprise readiness for critical care environments. While Stethee Pro 1 is HIPAA compliant and cloud-based, its mobile-first approach may require more bespoke integration efforts into large hospital EMR systems compared to Tool A's inherent platform integration.
Innovation
Acumen Hypotension Prediction Index EV1000 Clinical PlatformAcumen HPI demonstrates superior innovation through its machine learning-based algorithm that proactively predicts hypotensive events up to 15 minutes in advance and identifies potential root causes, a critical advancement in patient safety and proactive care. While Stethee Pro 1's AI-enabled digital stethoscope is innovative for diagnostics and remote monitoring, Acumen HPI's predictive capability for a time-sensitive, life-threatening condition represents a more groundbreaking clinical application.
Support & Docs
Acumen Hypotension Prediction Index EV1000 Clinical PlatformEdwards Lifesciences, as a large and established medical device company, provides extensive support, training, and comprehensive documentation for its products like Acumen HPI, including clinical education and technical support. M3DICINE, while offering support for Stethee Pro 1, is a smaller company, and its support infrastructure is likely less extensive or globally distributed.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Acumen Hypotension Prediction Index EV1000 Clinical Platform | Stethee Pro 1 |
|---|---|---|
| Name | Acumen Hypotension Prediction Index u2013 EV1000 Clinical Platform | Stethee Pro 1 |
| Company | Edwards Lifesciences | M3DICINE Pty Ltd. |
| Tagline | Predicting and managing hypotension before it occurs. | The World's First AI-Enabled Wireless Stethoscope System for Advanced Cardiac and Respiratory Diagnostics. |
| Categories | Cardiology AI, Surgical AI, Triage & ER/ICU AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Specialties | Anesthesiology, Critical Care, Emergency Medicine | Cardiology, Emergency Medicine, Pulmonology |
| Key Features (Examples) | HPI Parameter (0-100 likelihood score), Smart Alerts for trending hypotension, Predicts hypotension up to 15 minutes in advance | AI-enabled wireless digital stethoscope system, Captures cardiac and respiratory vital signs in 20 seconds, Sophisticated sound amplification (up to 96x) |
Videos
Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index EV1000 Clinical Platform and Stethee Pro 1.